Memo of Meeting Date: August 7, 2002 Representing Daon, Co. of Dublin Ireland: James Dunn, Senior Technical Sales Consultant Martin Walsh, VP Regulatory Affairs Representing FDA:

First Page		Document Content
Date: 2002-11-08 11:21:10 Surveillance Biometrics Identification Food and Drug Administration Title 21 CFR Part 11 Electronic signature Daon Inc. Pharmaceutical sciences Security Medicine		Memo of Meeting Date: August 7, 2002 Representing Daon, Co. of Dublin Ireland: James Dunn, Senior Technical Sales Consultant Martin Walsh, VP Regulatory Affairs Representing FDA: Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 163,94 KB Share Document on Facebook

	Evaluating Behavioral Biometrics for Continuous Authentication: Challenges and Metrics Simon Eberz Kasper B. Rasmussen DocID: 1xVQY - View Document
	CASE STUDY VOICE BIOMETRICS JUST THE VOICE TO VERIFY THE IDENTITY OF TATRA BANKA CLIENTS COMPANY: Tatra Banka DocID: 1xUAY - View Document
	Broken Hearted: How To Attack ECG Biometrics Simon Eberz Nicola Paoletti Marc Roeschlin DocID: 1xUjz - View Document
	PDF Document DocID: 1xSV6 - View Document
	DOC Document DocID: 1xMH5 - View Document